πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8329924

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8329662

Prodrug of an ICE inhibitor

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324220

Pyrimidines useful as modulators of voltage-gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324242

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8324207

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8318733

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8318467

Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8314141

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8314256

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8314239

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8314125

Bicyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8309587

Piperidine and piperazine phenyl sulphonamides as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8309543

Compositions useful as inhibitors of voltage-gated sodium channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8304414

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8304423

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8299099

Heteroaryl derivatives as CFTR modulators

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8293929

Processes and intermediates

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8288537

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8288400

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8278306

C-met protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8278297

Protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8273896

Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8268829

Substituted pyrimidines useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8269026

Lupane derivatives useful for treating HIV

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted